- Home
- ERNA vs TLPH Comparison
ERNA vs TLPH Comparison
Compare ERNA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- TLPH
- Stock Information
- Founded
- ERNA 2018
- TLPH 2005
- Country
- ERNA United States
- TLPH United States
- Employees
- ERNA N/A
- TLPH N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- ERNA Health Care
- TLPH Health Care
- Exchange
- ERNA Nasdaq
- TLPH Nasdaq
- Market Cap
- ERNA 10.2M
- TLPH 11.1M
- IPO Year
- ERNA N/A
- TLPH 2011
- Fundamental
- Price
- ERNA $1.29
- TLPH $0.93
- Analyst Decision
- ERNA
- TLPH Strong Buy
- Analyst Count
- ERNA 0
- TLPH 1
- Target Price
- ERNA N/A
- TLPH $6.00
- AVG Volume (30 Days)
- ERNA 80.1K
- TLPH 7.3M
- Earning Date
- ERNA 11-11-2025
- TLPH 11-12-2025
- Dividend Yield
- ERNA N/A
- TLPH N/A
- EPS Growth
- ERNA N/A
- TLPH N/A
- EPS
- ERNA N/A
- TLPH N/A
- Revenue
- ERNA $488,000.00
- TLPH $27,000.00
- Revenue This Year
- ERNA N/A
- TLPH N/A
- Revenue Next Year
- ERNA N/A
- TLPH $14,533.26
- P/E Ratio
- ERNA N/A
- TLPH N/A
- Revenue Growth
- ERNA 201.24
- TLPH N/A
- 52 Week Low
- ERNA $1.19
- TLPH $0.38
- 52 Week High
- ERNA $23.70
- TLPH $1.20
- Technical
- Relative Strength Index (RSI)
- ERNA 37.60
- TLPH 79.40
- Support Level
- ERNA $1.19
- TLPH $0.40
- Resistance Level
- ERNA $1.57
- TLPH $1.07
- Average True Range (ATR)
- ERNA 0.14
- TLPH 0.13
- MACD
- ERNA 0.01
- TLPH 0.05
- Stochastic Oscillator
- ERNA 26.32
- TLPH 61.44
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.